Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy
暂无分享,去创建一个
A. Romero-Ruiz | J. Briceño-Delgado | D. Cortés-Guiral | J. Sánchez-Hidalgo | Á. Arjona-Sánchez | S. Rufián-Peña | P. Villarejo-Campos | F. Valenzuela-Molina | B. Rufian-Andujar | M. Durán-Martínez | L. Rodriguez-Ortiz | Á. Casado-Adam | E. Espinosa-Redondo | B. Rufián-Andújar
[1] J. Briceño-Delgado,et al. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis , 2020, Surgical Endoscopy.
[2] J. Sánchez-Hidalgo,et al. Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice. , 2019, Surgical oncology.
[3] J. Briceño-Delgado,et al. Colorectal peritoneal metastases: Optimal management review , 2019, World journal of gastroenterology.
[4] Jae-Weon Kim,et al. A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms , 2019, The New England journal of medicine.
[5] M. Pocard,et al. A UNICANCER phase III trial of Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Carcinomatosis. PRODIGE 7. , 2019, European Journal of Surgical Oncology.
[6] Lynette M. Smith,et al. Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures , 2019, JAMA network open.
[7] J. Esquivel,et al. A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis , 2018, Surgical Endoscopy.
[8] M. Pocard,et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. , 2018, Journal of Clinical Oncology.
[9] J. Briceño-Delgado,et al. Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy (HIPEC) by Minimally Invasive Approach, an Initial Experience , 2018, World Journal of Surgery.
[10] F. Ghezzi,et al. Laparoscopic Management of Ovarian Cancer Patients With Localized Carcinomatosis and Lymph Node Metastases: Results of a Retrospective Multi-institutional Series. , 2016, Journal of minimally invasive gynecology.
[11] T. Chua,et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery , 2014, Journal of surgical oncology.
[12] E. Cotte,et al. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[13] T. Chua,et al. Laparoscopic Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Limited Peritoneal Surface Malignancies: Feasibility, Morbidity and Outcome in an Early Experience , 2011, Annals of surgery.
[14] T. Chua,et al. Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure?: A Systematic Review of Morbidity and Mortality , 2009, Annals of surgery.